Actively Recruiting
Evaluating Skin Irritation and Sensitization of EstradiolLevonorgestrel Transdermal Patches Compared to Climara Pro in Healthy Postmenopausal Women
Led by Corium Innovations, Inc. · Updated on 2026-09-10
250
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating two transdermal patches containing selegiline to compare their effects on skin irritation and allergic reactions in healthy postmenopausal women aged 40 to 75 years. The study is a phase 1, multi-center, evaluator-blinded, randomized trial assessing the skin tolerance and sensitization potential of the EstradiolLevonorgestrel Transdermal Delivery System TDS compared to the Climara Pro4 TDS. Participants will undergo a Screening Phase lasting five weeks followed by a Treatment Phase, which includes an Induction Period, a Rest Period, a Challenge Period, and if necessary, a Re-Challenge Period. The interventions involve simultaneous application of half patches of both the test product and the comparator patch on different buttock areas. Trained staff will regularly check patch adhesion and examine the skin at application sites using standardized FDA assessment scales. Throughout the study, participants will have scheduled assessments for signs of skin irritation and allergic reactions, with scoring performed shortly after patch removal on specified days. Safety will be monitored by recording any adverse events or discomfort. The primary outcomes include the mean irritation score during a 21-day continuous application and the number of participants showing possible sensitization after challenge or rechallenge. The total participation period extends from screening through treatment and follow-up evaluations.
CONDITIONS
Brief Title
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
Research Team
A
Ann Vollmer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here